M. KORİ Et Al. , "A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine," OMICS A Journal of Integrative Biology , vol.28, no.2, pp.90-101, 2024
KORİ, M. Et Al. 2024. A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine. OMICS A Journal of Integrative Biology , vol.28, no.2 , 90-101.
KORİ, M., Demirtas, T. Y., Comertpay, B., ARGA, K. Y., Sinha, R., & Gov, E., (2024). A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine. OMICS A Journal of Integrative Biology , vol.28, no.2, 90-101.
KORİ, MEDİ Et Al. "A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine," OMICS A Journal of Integrative Biology , vol.28, no.2, 90-101, 2024
KORİ, MEDİ Et Al. "A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine." OMICS A Journal of Integrative Biology , vol.28, no.2, pp.90-101, 2024
KORİ, M. Et Al. (2024) . "A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine." OMICS A Journal of Integrative Biology , vol.28, no.2, pp.90-101.
@article{article, author={MEDİ KORİ Et Al. }, title={A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine}, journal={OMICS A Journal of Integrative Biology}, year=2024, pages={90-101} }